Biotechnology (14) | Funding Agreements (14)

Browse by Company

ARYA Sciences Acquisition Corp II (2)
BioCardia, Inc. (1)
Biohaven Pharmaceutical Holding Co Ltd. (1)
Cytokinetics, Incorporated (1)
DiaMedica Therapeutics Inc. (1)
Kodiak Sciences Inc. (1)
NOVAVAX INC (2)
RITTER PHARMACEUTICALS INC (1)
VBI Vaccines Inc (2)
VICAL INC (1)
Xenetic Biosciences, Inc. (1)

Recent Contracts

Master Agreement for the Operational and Technological Funding of NanoSynex between Qualigen Therapeutics, Inc. and NanoSynex Ltd., dated May 26, 2022 (RITTER PHARMACEUTICALS INC, Filed With SEC on June 2, 2022)
Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic... (VBI Vaccines Inc, Filed With SEC on March 7, 2022)
Funding Agreement, dated as of April 12, 2021, by and between Cerevel Therapeutics, Inc. and NovaQuest Co-Investment Fund XVI, L.P (ARYA Sciences Acquisition Corp II, Filed With SEC on May 17, 2021)
Funding Agreement, dated as of April 12, 2021, by and between Cerevel Therapeutics, Inc. and BC Pinnacle Holdings, LP (ARYA Sciences Acquisition Corp II, Filed With SEC on May 17, 2021)
Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic... (VBI Vaccines Inc, Filed With SEC on May 10, 2021)
Amendment Number 1 to the iPDP and Budget of the Outbreak Response Funding Agreement (Step 2), entered into on November 2, 2020, between Novavax, Inc. and the Coalition for... (NOVAVAX INC, Filed With SEC on March 1, 2021)
Funding Agreement by and (Biohaven Pharmaceutical Holding Co Ltd., Filed With SEC on November 9, 2020)
Funding Agreement, dated July 14, 2020, by and between the Company and Dolya Holdco 19 Designated Activity Company (Cytokinetics, Incorporated, Filed With SEC on November 6, 2020)
Research Funding and Option Agreement, dated May 15, 2020, between the Company and the Scripps Research Institute (Xenetic Biosciences, Inc., Filed With SEC on August 12, 2020)
Restated Funding Agreement, entered into on May 11, 2020, by and between the Company and the Coalition for Epidemic Preparedness Innovations (NOVAVAX INC, Filed With SEC on August 10, 2020)